Frost & Sullivan

Healthcare


Analysis of the European Bipolar-disorder Therapeutics Market

Improving New Drug Formulations and Strong Product Pipelines Expected to Restore Growth beyond 2013
Share this:

This research service provides an assessment of the European bipolar-disorder therapeutics market, maps the key trends and dynamics shaping the industry, provides valuable insights on pipeline analysis and competitive landscape and offers strategic recommendations for the success of the market participants. This study provides an in-depth analysis of the market in terms of the three major classes of drugs used for treatment—atypical antipsychotics, mood stabilisers and anti-depressants—with a specific focus on the key five countries in Europe: Germany, France, the United Kingdom, Italy and Spain.

Click headings to expand and collapse Author: Aiswariya Chidambaram | 18 May 2012
  1.  
  2.  
  3.  
    •  
      Overview of the European Bipolar-disorder Therapeutics Market
  4.  
  5.  
  6.  
  7.  
  8.  
  9.  
  10.  
  11.  
  12.  
  13.  
  14.  
  15.  
  16.  
  17.  
  18.  
  19.  
  20.  
  21.  
  22.  
  23.  

Tools

Features of this research

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..